Characterization of TRPC6 to predict and prevent chemotherapy-related cardiomyopathy and heart failure in women

Ended Project Grant Awarded Last action

Award ID
W81XWH2210288
Recipient
Awarding agency
Obligated
$1,770,360

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Jacksonville, FL 32224, USA

Award details come from USAspending.gov.

About this award

The Department of the Army Medical Command awarded Mayo Clinic Jacksonville a $1,770,360 Project Grant under the Military Medical Research and Development program to characterize TRPC6 to predict and prevent chemotherapy-related cardiomyopathy and heart failure in women. The grant will support research from June 2022 to June 2026 to transform military and public health care through innovative medical solutions for the battlefield and investigation of solutions for conditions like chemotherapy-related heart damage. As the prime awardee, Mayo Clinic Jacksonville will lead the research effort to develop methods to characterize TRPC6 to predict and prevent chemotherapy-related cardiomyopathy and subsequent heart failure in female patients, in support of the Military Medical Research and Development program's goals.

Quick answers

Who received award W81XWH2210288?

W81XWH2210288 was awarded to Mayo Clinic Jacksonville (A Nonprofit Corporation) by Medical Command (Department of the Army) on June 15, 2022.

How much is award W81XWH2210288 worth?

$1,770,360 has been obligated on W81XWH2210288.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award